Beijing Konruns Pharmaceutical Co., Ltd. Class ASSE: 603590

Announcement on Presentation of Preclinical Study Data of Innovative Drugs KC1086 and KC1101 at the AACR Annual Meeting 2026

· Issued by Beijing Konruns Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Presentation of Preclinical Study Data of Innovative Drugs KC1086 and KC1101 at the AACR Annual Meeting 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis